Ondine Biomedical Inc. (AIM:OBI)
London · Delayed Price · Currency is GBP · Price in GBX 14.84
+0.09 (0.61%)
Jun 16, 2026, 9:59 AM GMT
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 76.63 million as of June 16, 2026. Its market cap has increased by 103.41% in one year.
Market Cap
76.63M
Enterprise Value
71.13M
Revenue
1.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.84
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 76.63M, a decrease of -32.10%. That is a compound annual growth rate of -8.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 67.54M | 73.76% |
| Dec 31, 2025 | 38.87M | 9.33% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
| Dec 6, 2021 | 112.86M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 202.37M |
| Faron Pharmaceuticals Oy | 91.30M |
| Bioventix | 84.90M |
| 4basebio | 81.58M |
| hVIVO | 58.05M |
| Hemogenyx Pharmaceuticals | 56.13M |
| Poolbeg Pharma | 54.29M |
| Sareum Holdings | 31.87M |